Anti human ovarian cancer-anti CD3 bispecific antibody
    2.
    发明授权
    Anti human ovarian cancer-anti CD3 bispecific antibody 失效
    抗人卵巢癌抗CD3双特异性抗体

    公开(公告)号:US07262276B2

    公开(公告)日:2007-08-28

    申请号:US10478345

    申请日:2002-05-23

    IPC分类号: C07K16/30

    摘要: The present invention provides an anti-ovarian cancer bispecific antibody. Said antibody includes two polypeptide domains connected by a polypeptide linker, one is anti-ovarian cancer antibody, or its Fab fragment, single complementarity determining region (CDR) antibody or single chain Fv (scFv) and the other is anti-CD3 antibody, or its Fab fragment, single CDR antibody or scFv. The present invention also provides DNA sequences encoding said antibody, an expression vector containing said DNA sequence, and a host cell containing said expression vector.

    摘要翻译: 本发明提供了抗卵巢癌双特异性抗体。 所述抗体包括通过多肽接头连接的两个多肽结构域,一个是抗卵巢癌抗体或其Fab片段,单互补决定区(CDR)抗体或单链Fv(scFv),另一个是抗CD3抗体,或 其Fab片段,单CDR抗体或scFv。 本发明还提供编码所述抗体的DNA序列,含有所述DNA序列的表达载体和含有所述表达载体的宿主细胞。